Published in Scand J Gastroenterol on August 01, 2003
Integrated Treatment of Hepatitis C Virus Infection (INTRO-HCV) | NCT03155906
Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol (2013) 3.25
Epidemiology and natural history of hepatitis C virus infection. World J Gastroenterol (2014) 1.11
Hepatitis C virus and alcohol. Semin Liver Dis (2009) 1.08
Recommendations on hepatitis C screening for adults. CMAJ (2017) 1.07
Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy. World J Gastroenterol (2014) 0.98
Hepatitis C prevalence in Denmark -an estimate based on multiple national registers. BMC Infect Dis (2012) 0.90
Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013. Scand J Gastroenterol (2015) 0.86
Socioeconomic status in HCV infected patients - risk and prognosis. Clin Epidemiol (2013) 0.83
High Prevalence of Hepatitis C virus Among Injection Drug Users in Zhenjiang, Jiangsu, China. Indian J Virol (2011) 0.81
Hepatitis C as a prognostic indicator among noncirrhotic patients hospitalized with alcoholic hepatitis. Can J Gastroenterol (2013) 0.77
The north-to-south gradient of hepatitis C virus infection. Scand J Gastroenterol (2003) 0.77
Epidemiology of hepatitis C in Croatia in the European context. World J Gastroenterol (2015) 0.75
Future complications of chronic hepatitis C in a low-risk area: projections from the hepatitis c study in Northern Norway. BMC Infect Dis (2017) 0.75
Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much? Curr Hepatol Rep (2017) 0.75
Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973-2030. BMC Infect Dis (2017) 0.75
Application of the passive haemolysis test for the determination of rubella virus antibodies. Acta Pathol Microbiol Scand B (1975) 2.66
[Genetic diagnostic test for hemochromatosis]. Tidsskr Nor Laegeforen (1998) 2.02
Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Community Health (1989) 1.92
Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion (1997) 1.92
Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2). J Virol Methods (1992) 1.86
Differentiation between herpes simplex virus type 1 and type 2 strains by immunoelectroosmophoresis. Appl Microbiol (1972) 1.86
Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy. J Intern Med (2002) 1.80
Pelvic inflammatory disease associated with Chlamydia trachomatis infection after therapeutic abortion. A prospective study. Br J Vener Dis (1983) 1.69
False-negative results of a ligase chain reaction assay to detect Chlamydia trachomatis due to inhibitors in urine. Eur J Clin Microbiol Infect Dis (1997) 1.61
The use of malaria antibody tests in the prevention of transfusion-transmitted malaria. Vox Sang (2010) 1.60
Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol (1998) 1.57
Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. J Gen Virol (1995) 1.55
Therapeutic abortion and Chlamydia trachomatis infection. Br J Vener Dis (1982) 1.53
Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection. Liver (2002) 1.48
Unusual lectin-binding properties of a herpes simplex virus type 1-specific glycoprotein. J Virol (1981) 1.48
Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens. J Clin Microbiol (1984) 1.48
HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis. Gut (2000) 1.47
Second-generation anti-HCV tests predict infectivity. Vox Sang (1992) 1.43
Neuropathological findings after intracerebral implantation of microdialysis catheters. Neuroreport (1998) 1.41
Reinventing long-term care. Minn Med (2001) 1.39
Joining the ranks of the employed. Minn Med (1996) 1.37
Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies. J Gen Virol (1998) 1.37
Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up. Eur Addict Res (2002) 1.35
Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate. J Gen Virol (1994) 1.35
Typing of herpes simplex virus by an enzyme-linked immunosorbent assay with monoclonal antibodies. J Clin Microbiol (1983) 1.34
Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides. Proc Natl Acad Sci U S A (1991) 1.34
Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int J STD AIDS (1994) 1.34
Diagnosis of recent Herpes simplex infections. A modified immunofluorescent test for the detection of specific Herpes simplex IgM antibodies after staphylococcal adsorption of IgG. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 1.33
The diagnostic value of determination of IgM antibodies against Mycoplasma pneumoniae by the indirect immunofluorescent antibody test. Acta Pathol Microbiol Scand B (1976) 1.29
Involvement of glycoprotein C (gC) in adsorption of herpes simplex virus type 1 (HSV-1) to the cell. Arch Virol (1991) 1.27
Genital herpesvirus hominis infection: a venereal disease? Lancet (1970) 1.26
Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver diseases. J Intern Med (1994) 1.25
Herpes simplex virus type 2 antibody in patients attending antenatal or STD clinics. Med J Aust (1993) 1.22
Identification of high levels of protein phosphatase-1 in rat liver nuclei. FEBS Lett (1986) 1.22
Preparation of type specific herpes simplex antisera by an immunosorbent method;. Acta Pathol Microbiol Scand B (1975) 1.21
Proliferative human T cell responses to Chlamydia trachomatis in vitro. Acta Pathol Microbiol Immunol Scand C (1983) 1.19
Sensitivity of western blotting (compared with ELISA and immunofluorescence) during seroconversion after HTLV-III infection. Lancet (1986) 1.17
Evaluation of solubilized herpes simplex virus membrane antigens in diffusion in gel-enzyme-linked immunosorbent assay (DIG-ELISA). J Virol Methods (1982) 1.16
Characterization of a herpes simplex virus type 2-specified glycoprotein with affinity for N-acetylgalactosamine-specific lectins and its identification as g92K or gG. J Gen Virol (1986) 1.14
Vectorcardiographic evolution of left ventricular hypertrophy. Br Heart J (1968) 1.14
Association between HLA-BW40 and alcoholic liver disease with cirrhosis. Br Med J (1978) 1.13
Carbohydrate determinant NeuAc-Gal beta (1-4) of N-linked glycans modulates the antigenic activity of human immunodeficiency virus type 1 glycoprotein gp120. J Gen Virol (1992) 1.13
Glycoprotein C of herpes simplex virus type 1: characterization of O-linked oligosaccharides. J Gen Virol (1983) 1.12
Primary and recurrent herpes simplex virus type 2-induced meningitis. J Infect Dis (1990) 1.11
Longitudinal observation of enterovirus and adenovirus in stool samples from Norwegian infants with the highest genetic risk of type 1 diabetes. J Clin Virol (2006) 1.11
Herpes simplex virus type 1-induced hemagglutination: glycoprotein C mediates virus binding to erythrocyte surface heparan sulfate. J Virol (1993) 1.11
Kinetics of thiamin and thiamin phosphate esters in human blood, plasma and urine after 50 mg intravenously or orally. Eur J Clin Pharmacol (1993) 1.11
A 15-year surveillance study of antibodies to herpes simplex virus types 1 and 2 in a cohort of young girls. J Infect (1992) 1.10
Fecal calprotectin concentration in patients with colorectal carcinoma. Dis Colon Rectum (1998) 1.09
Regulation of development in the fully grown mouse oocyte: chromosome-mediated temporal and spatial differentiation of the cytoplasm and plasma membrane. J Embryol Exp Morphol (1986) 1.06
The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy? Eur Respir J (1994) 1.06
Characterization of the binding epitope of a monoclonal antibody to sulphatide. Biochem J (1988) 1.05
Comparison of the sensitivity of four rapid assays for the detection of antibodies to HIV-1/HIV-2 during seroconversion. Clin Diagn Virol (1996) 1.05
Herpes simplex virus type 2 in acute aseptic meningitis. Br Med J (1973) 1.04
Low-grade intestinal lymphoma of intraepithelial T lymphocytes with concomitant enteropathy-associated T cell lymphoma: case report suggesting a possible histogenetic relationship. Hum Pathol (1989) 1.04
Evaluation of solubilized herpes simplex virus membrane antigen by enzyme-linked immunosorbent assay. J Clin Microbiol (1983) 1.04
Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS. AIDS (1992) 1.04
Chlamydial serum IgG antibodies in patients with acute salpingitis measured by an enzyme-linked immunosorbent assay. Acta Pathol Microbiol Immunol Scand C (1982) 1.03
Strategies for assessing the implications of malformed frogs for environmental health. Environ Health Perspect (2000) 1.03
Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre study. Scand J Gastroenterol (2002) 1.02
Utilization of endoscopic inoculation in a mouse model of intrauterine infection-induced preterm birth: role of interleukin 1beta. Biol Reprod (1999) 1.01
Amplified ELISPOT assay for the detection of HIV-specific antibody-secreting cells in subhuman primates. J Immunol Methods (1992) 1.01
Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1994) 1.00
Relationship of secretion pattern and MPB70 homology with osteoblast-specific factor 2 to osteitis following Mycobacterium bovis BCG vaccination. Infect Immun (1995) 1.00
Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit. Scand J Gastroenterol (2004) 1.00
Mapping neuroinvasiveness of the herpes simplex virus type 1 encephalitis-inducing strain 2762 by the use of monoclonal antibodies. Mol Cell Probes (1992) 1.00
Large-scale production of monoclonal antibodies in dialysis tubing. J Immunol Methods (1985) 1.00
Identification of group-common linear epitopes in structural and nonstructural proteins of enteroviruses by using synthetic peptides. J Clin Microbiol (1993) 0.99
Ocular illness in association with adenovirus type 3 infection. An epidemic of conjunctivitis and keratoconjunctivitis in Stockholm 1969. Scand J Infect Dis (1973) 0.99
Concomitant determination of thiamin and its phosphate esters in human blood and serum by high-performance liquid chromatography. J Chromatogr (1991) 0.99
Production of herpes simplex antisera with increased type specificity in guinea pigs by antibody suppression. Proc Soc Exp Biol Med (1974) 0.99
Genital herpes infection and non-specific urethritis. Br Med J (1971) 0.98
Oxygen uptake/heart rate relationship in leg and arm exercise, sitting and standing. J Appl Physiol (1975) 0.98
Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia. QJM (1999) 0.97
An indirect immunofluorescent antibody test for determination of Rubella virus specific IgM antibodies. Elimination of secondary IgM rheumatoid factor staining after absorption of serum IgG with Staphylococcal protein A. Acta Pathol Microbiol Scand C (1978) 0.97
A rubella epidemic in an unvaccinated pregnant population. I. Screening methods and serological results. Scand J Infect Dis (1981) 0.97
Blood and serum thiamin and thiamin phosphate esters concentrations in patients with alcohol dependence syndrome before and after thiamin treatment. Alcohol Clin Exp Res (1992) 0.96
Report on the Mycological Diagnostic Laboratory, the Queen's University of Belfast, 1960. Ulster Med J (1961) 0.96
Long-term persistence of intrathecal virus-specific antibody responses after herpes simplex virus encephalitis. J Neurol (1985) 0.96
Relevance of a combined HIV antigen/antibody assay to detect early HIV infections in a low prevalence population: case reports. Clin Lab (2004) 0.96
A rotavirus staphylococcal co-agglutination test. Acta Pathol Microbiol Immunol Scand B (1983) 0.96
Herpes simplex virus type 2 and acute aseptic meningitis. Clinical features of cases with isolation of herpes simplex virus from cerebrospinal fluids. Scand J Infect Dis (1975) 0.95
Demonstration and mapping of highly carbohydrate-dependent epitopes in the herpes simplex virus type 1-specified glycoprotein C. J Gen Virol (1987) 0.94
Correlation of herpes simplex virus types 1 and 2 with clinical features of infection. J Infect Dis (1977) 0.94
Thin-layer immunoassay for determination of antibodies to herpes simplex virus. J Clin Microbiol (1979) 0.94
Screening urine samples by leukocyte esterase test and ligase chain reaction for chlamydial infections among asymptomatic men. J Clin Microbiol (1995) 0.93
Host cell-induced differences in O-glycosylation of herpes simplex virus gC-1. I. Structures of nonsialylated HPA- and PNA-binding carbohydrates. Virology (1987) 0.93
Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens. Scand J Gastroenterol (1995) 0.93
An outbreak of hepatitis A among homosexuals linked to a family outbreak. Epidemiol Infect (2002) 0.93
Failure to demonstrate enterovirus aetiology in Swedish patients with dilated cardiomyopathy. J Med Virol (1993) 0.92
Is preeclampsia an infectious disease? Acta Obstet Gynecol Scand (2001) 0.91
Very high expression of an anti-carcinoembryonic antigen single chain Fv antibody fragment in the yeast Pichia pastoris. J Biotechnol (2000) 0.91
An immunoenzyme procedure for enumerating fibronectin-secreting cells. J Immunoassay (1984) 0.91